Integrated Filing — IndAS



General information about company

Scrip Code 539787
NSE Symbol HCG
MSEI Symbol NOTLISTED
ISIN INE075I01017
Name of company HEALTHCARE GLOBAL ENTERPRISES LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 12-11-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 05-11-2025
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Second quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Single segment
Description of single segment Healthcare Sector
Start date and time of board meeting 12-11-2025   10:30:00
End date and time of board meeting 12-11-2025   17:30:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 13-02-2025
Indicate Company website link for updated RPT policy of the Company https://www.hcgoncology.com/corporate-governance/#Policies-and-Guidelines
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
Disclosure of default on loans and debt securitirs is not applicable on the Company.



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2025 01-04-2025
B Date of end of reporting period 30-09-2025 30-09-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 34,584.00 67,293.00
Other income 382.00 1,176.00
Total income 34,966.00 68,469.00
2 Expenses
(a) Cost of materials consumed 0.00 0.00
(b) Purchases of stock-in-trade 9,077.00 17,501.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (140.00) (501.00)
(d) Employee benefit expense 5,286.00 10,927.00
(e) Finance costs 2,136.00 4,566.00
(f) Depreciation, depletion and amortisation expense 3,016.00 5,841.00
(f) Other Expenses
1 Medical Consultancy charges 6,563.00 12,991.00
2 Other Expenses 7,568.00 15,160.00
Total other expenses 14,131.00 28,151.00
Total expenses 33,506.00 66,485.00
3 Total profit before exceptional items and tax 1,460.00 1,984.00
4 Exceptional items 0.00 0.00
5 Total profit before tax 1,460.00 1,984.00
6 Tax expense
7 Current tax 438.00 772.00
8 Deferred tax (56.00) (211.00)
9 Total tax expenses 382.00 561.00
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 1,078.00 1,423.00
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 1,078.00 1,423.00
17 Other comprehensive income net of taxes (11.00) (11.00)
18 Total Comprehensive Income for the period 1,067.00 1,412.00
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 14,100.00 14,100.00
Face value of equity share capital 10 10
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 0.77 1.02
Diluted earnings (loss) per share from continuing operations 0.77 1.01
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 0.77 1.02
Diluted earnings (loss) per share from continuing and discontinued operations 0.77 1.01
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 30-09-2025
Whether results are audited or unaudited Unaudited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 90,823.00
Capital work-in-progress 5,850.00
Investment property 0.00
Goodwill 9,014.00
Other intangible assets 1,003.00
Intangible assets under development 0.00
Biological assets other than bearer plants 0.00
Investments accounted for using equity method 0.00
Non-current financial assets
Non-current investments 69,585.00
Trade receivables, non-current 0.00
Loans, non-current 3,965.00
Other non-current financial assets 7,824.00
Total non-current financial assets 81,374.00
Deferred tax assets (net) 0.00
Other non-current assets 12,452.00
Total non-current assets 2,00,516.00
2 Current assets
Inventories 2,477.00
Current financial asset
Current investments 0.00
Trade receivables, current 27,804.00
Cash and cash equivalents 11,023.00
Bank balance other than cash and cash equivalents 0.00
Loans, current 188.00
Other current financial assets 8,565.00
Total current financial assets 47,580.00
Current tax assets (net) 0.00
Other current assets 4,390.00
Total current assets 54,447.00
3 Non-current assets classified as held for sale 0.00
4 Regulatory deferral account debit balances and related deferred tax Assets 0.00
Total assets 2,54,963.00
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 14,100.00
Other equity 1,04,324.00
Total equity attributable to owners of parent 1,18,424.00
Non controlling interest
Total equity 1,18,424.00
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 32,001.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0.00
Total Trade payable 0.00
Other non-current financial liabilities 42,690.00
Total non-current financial liabilities 74,691.00
Provisions, non-current 1,305.00
Deferred tax liabilities (net) 306.00
Deferred government grants, Non-current 0.00
Other non-current liabilities 3,575.00
Total non-current liabilities 79,877.00
Current liabilities
Current financial liabilities
Borrowings, current 23,193.00
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 273.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 16,102.00
Total Trade payable 16,375.00
Other current financial liabilities 8,297.00
Total current financial liabilities 47,865.00
Other current liabilities 5,379.00
Provisions, current 1,515.00
Current tax liabilities (Net) 1,903.00
Deferred government grants, Current 0.00
Total current liabilities 56,662.00
3 Liabilities directly associated with assets in disposal group classified as held for sale 0.00
4 Regulatory deferral account credit balances and related deferred tax liability 0.00
Total liabilities 1,36,539.00
Total equity and liabilites 2,54,963.00
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-07-2025 01-04-2025
Date of end of reporting period 30-09-2025 30-09-2025
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2025 01-04-2025
B Date of end of reporting period 30-09-2025 30-09-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurements of the defined benefit plans -1500000 -1500000
2 Income tax effect on above 400000 400000
Total Amount of items that will not be reclassified to profit and loss (11.00) (11.00)
2 Income tax relating to items that will not be reclassified to profit or loss 0.00 0.00
3 Amount of items that will be reclassified to profit and loss
1 Effective portion of gain on hedging instruments in cash flow hedge 0 0
2 Income tax effect on above 0 0
Total Amount of items that will be reclassified to profit and loss 0.00 0.00
4 Income tax relating to items that will be reclassified to profit or loss 0.00 0.00
5 Total Other comprehensive income (11.00) (11.00)



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 30-09-2025
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 1,984.00
Adjustments for reconcile profit (loss)
Adjustments for finance costs 4,566.00
Adjustments for decrease (increase) in inventories (501.00)
Adjustments for decrease (increase) in trade receivables, current (2,174.00)
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets (3,031.00)
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current 0.00
Adjustments for other financial assets, current 0.00
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current 4,326.00
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities 0.00
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 5,841.00
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current (39.00)
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current 0.00
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains (21.00)
Adjustments for dividend income 0.00
Adjustments for interest income 842.00
Adjustments for share-based payments (5,688.00)
Adjustments for fair value losses (gains) 0.00
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) 364.00
Other adjustments for non-cash items 0.00
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) 2,801.00
Net cash flows from (used in) operations 4,785.00
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) (1,730.00)
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 6,515.00
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 139.00
Purchase of property, plant and equipment 7,431.00
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 0.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 10,302.00
Net cash flows from (used in) investing activities 3,010.00
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 2,403.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 5,138.00
Repayments of borrowings 4,712.00
Payments of lease liabilities 1,863.00
Dividends paid 0.00
Interest paid 2,572.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash (2,237.00)
Net cash flows from (used in) financing activities (3,843.00)
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 5,682.00
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents 5,682.00
Cash and cash equivalents cash flow statement at beginning of period (12,175.00)
Cash and cash equivalents cash flow statement at end of period (6,493.00)





Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 HealthCare Global Enterprises Limited HCG Medi-surge Hospitals Private Limited Subsidiary Company Sale of goods or services 20.00 Approved 6.89 14.30 21.10 Any other NA 0.00 Not Applicable
2 HealthCare Global Enterprises Limited HCG Medi-surge Hospitals Private Limited Subsidiary Company Purchase of goods or services 150.00 Approved 0.00 0.00 0.00 Any other NA 0.00 Not Applicable
3 HealthCare Global Enterprises Limited HCG Medi-surge Hospitals Private Limited Subsidiary Company Sale of fixed assets 150.00 Approved 0.00 0.00 0.00 Any other NA 0.00 Not Applicable
4 HealthCare Global Enterprises Limited HCG Medi-surge Hospitals Private Limited Subsidiary Company Any other transaction Expense from diagnostic and other medical services 12.50 Approved 6.30 12.40 13.70 Any other NA 0.00 Not Applicable
5 HealthCare Global Enterprises Limited HCG Medi-surge Hospitals Private Limited Subsidiary Company Any other transaction Reimbursement of capital expenditure/ revenue expenditure cross charged by the Company 136.70 Approved 136.70 0.00 0.00 Any other NA 0.00 Not Applicable
6 HealthCare Global Enterprises Limited HCG Medi-surge Hospitals Private Limited Subsidiary Company Any other transaction Payments on behalf of 307.90 Approved 307.90 608.80 961.40 Any other NA 0.00 Not Applicable
7 HCG Medi-surge Hospitals Private Limited HCG Foundation Company / entity in which KMP / Relatives of KMP can exercise significant influence Sale of goods or services 0.00 Approved 20.02 0.53 9.41 Any other NA 0.00 Not Applicable
8 HCG Medi-surge Hospitals Private Limited HCG Oncology LLP Subsidiary LLP Sale of fixed assets 0.00 Approved 0.00 0.39 0.39 Any other NA 0.00 Not Applicable
9 HCG Medi-surge Hospitals Private Limited HCG Oncology LLP Subsidiary LLP Any other transaction Reimbursement of capital expenditure/ revenue expenditure cross charged by the Company 0.00 Approved 0.08 1.40 1.48 Any other NA 0.00 Not Applicable
10 HCG Medi-surge Hospitals Private Limited HCG Oncology LLP Subsidiary LLP Sale of goods or services 2.64 Approved 2.64 0.00 2.64 Any other NA 0.00 Not Applicable
11 HCG Medi-surge Hospitals Private Limited HCG Oncology LLP Subsidiary LLP Purchase of goods or services 7.55 Approved 7.55 0.00 7.55 Any other NA 0.00 Not Applicable
12 HCG Medi-surge Hospitals Private Limited Astha Oncology Private Limited Company / entity in which KMP / Relatives of KMP can exercise significant influence Any other transaction Medical Consultant fee 2,978.55 Approved 2,978.55 346.22 404.67 Any other NA 0.00 Not Applicable
13 HCG Medi-surge Hospitals Private Limited Astha Oncology Private Limited Company / entity in which KMP / Relatives of KMP can exercise significant influence Sale of goods or services 0.00 Approved 0.00 0.00 0.00 Any other NA 0.00 Not Applicable
14 HCG Medi-surge Hospitals Private Limited HCG RAJKOT HOSPITALS LLP (Formerly known as HCG Sun Hospitals LLP) Wholly - owned subsidiary LLP Any other transaction Reimbursement of capital expenditure/ revenue expenditure cross charged by the Company 0.00 Not Applicable 0.20 3.05 3.25 Any other NA 0.00 Not Applicable
15 HCG Medi-surge Hospitals Private Limited HCG RAJKOT HOSPITALS LLP (Formerly known as HCG Sun Hospitals LLP) Wholly - owned subsidiary LLP Sale of goods or services 0.00 Not Applicable 0.27 0.00 0.27 Any other NA 0.00 Not Applicable
16 HealthCare Global Enterprises Limited HCG Oncology LLP Subsidiary LLP Sale of goods or services 15.00 Approved 1.68 0.00 0.00 Any other NA 0.00 Not Applicable
17 HealthCare Global Enterprises Limited HCG Oncology LLP Subsidiary LLP Sale of fixed assets 100.00 Approved 100.00 0.00 3.35 Any other NA 0.00 Not Applicable
18 HealthCare Global Enterprises Limited HCG Oncology LLP Subsidiary LLP Purchase of goods or services 120.00 Approved 48.60 5.10 6.00 Any other NA 0.00 Not Applicable
19 HealthCare Global Enterprises Limited HCG Oncology LLP Subsidiary LLP Any other transaction Corporate guarantee commission income received 10.50 Approved 6.10 0.00 0.00 Any other NA 0.00 Not Applicable
20 HealthCare Global Enterprises Limited HCG Oncology LLP Subsidiary LLP Any other transaction Reimbursement of expense on employee stock option scheme cross charged by the Company 1.50 Approved 1.50 0.00 0.00 Any other NA 0.00 Not Applicable
21 HealthCare Global Enterprises Limited HCG Oncology LLP Subsidiary LLP Any other transaction Reimbursement of capital expenditure/ revenue expenditure cross charged by the Company 19.80 Approved 19.80 0.00 0.00 Any other NA 0.00 Not Applicable
22 HealthCare Global Enterprises Limited HCG Oncology LLP Subsidiary LLP Any other transaction Payments on behalf of 0.60 Approved 0.60 231.90 211.90 Any other NA 0.00 Not Applicable
23 HCG Oncology LLP Dr. Rajiv Gopinath Bhat Partner Any other transaction Medical Service 610.00 Approved 404.07 82.83 87.26 Any other NA 0.00 Not Applicable
24 HCG Oncology LLP HCG Foundation Company / entity in which KMP / Relatives of KMP can exercise significant influence Sale of goods or services Approved 1.08 1.50 2.58 Any other NA 0.00 Not Applicable
25 HCG Oncology LLP HCG RAJKOT HOSPITALS LLP (Formerly known as HCG Sun Hospitals LLP) Wholly - owned subsidiary LLP Sale of goods or services 0.00 Not Applicable 0.00 0.19 0.53 Any other NA 0.00 Not Applicable
26 HealthCare Global Enterprises Limited Nagpur Cancer Hospital and Research Institute Pvt Ltd Subsidiary Company Any other transaction Revenue Share 0.00 Not Applicable 5,687.54 3,556.60 4,287.70 Any other NA 0.00 Not Applicable
27 HCG NCHRI Oncology LLP HealthCare Global Enterprises Limited Parent Company Sale of goods or services 0.00 Not Applicable 1,644.50 286.09 781.77 Any other NA 0.00 Not Applicable
28 HCG NCHRI Oncology LLP HCG Medi-surge Hospitals Private Limited Fellow Subsidiary Sale of goods or services 625.00 Approved 522.04 639.05 313.05 Any other NA 0.00 Not Applicable
29 HCG NCHRI Oncology LLP Suchirayu Health Care Solutions Limited Fellow Subsidiary Sale of goods or services 0.00 Not Applicable 209.71 74.37 12.93 Any other NA 0.00 Not Applicable
30 HCG NCHRI Oncology LLP Malnad Hospital & Institute of Oncology Private Limited Fellow Subsidiary Sale of goods or services 0.00 Not Applicable 9.24 3.52 1.49 Any other NA 0.00 Not Applicable
31 HCG NCHRI Oncology LLP BACC Healthcare Private Limited Fellow Subsidiary Sale of goods or services 0.00 Not Applicable 9.59 26.76 20.40 Any other NA 0.00 Not Applicable
32 HCG NCHRI Oncology LLP HCG Oncology Hospitals LLP (formerly, Apex HCG Oncology Hospitals LLP) Fellow Subsidiary Sale of goods or services 0.00 Not Applicable 191.00 673.84 469.93 Any other NA 0.00 Not Applicable
33 HCG NCHRI Oncology LLP HCG RAJKOT HOSPITALS LLP (Formerly known as HCG Sun Hospitals LLP) Fellow Subsidiary Sale of goods or services 0.00 Not Applicable 2.14 1.40 3.37 Any other NA 0.00 Not Applicable
34 HCG NCHRI Oncology LLP HCG KOLKATA CANCER CARE LLP (Formerly known as HCG EKO Oncology LLP) Fellow Subsidiary Sale of goods or services 0.00 Not Applicable 214.53 803.50 818.07 Any other NA 0.00 Not Applicable
35 HCG NCHRI Oncology LLP HCG Oncology LLP Fellow Subsidiary Sale of goods or services 0.00 Not Applicable 5.82 0.72 8.23 Any other NA 0.00 Not Applicable
36 HealthCare Global Enterprises Limited HCG Foundation Company / entity in which KMP / Relatives of KMP can exercise significant influence Sale of goods or services 128.41 Approved 128.41 63.60 191.73 Any other NA 0.00 Not Applicable
37 HealthCare Global Enterprises Limited HCG Foundation Company / entity in which KMP / Relatives of KMP can exercise significant influence Any other transaction Other payable 0.00 Approved 0.00 1.70 1.70 Any other NA 0.00 Not Applicable
38 HealthCare Global Enterprises Limited Sada Sarada Tumor & Research Institute Company / entity in which KMP / Relatives of KMP can exercise significant influence Sale of goods or services 130.00 Approved 52.70 2.60 18.74 Any other NA 0.00 Not Applicable
39 HealthCare Global Enterprises Limited Sada Sarada Tumor & Research Institute Company / entity in which KMP / Relatives of KMP can exercise significant influence Any other transaction Rent 0.43 Approved 0.43 0.00 0.04 Any other NA 0.00 Not Applicable
40 HealthCare Global Enterprises Limited HCG Oncology Hospitals LLP (formerly, Apex HCG Oncology Hospitals LLP) Wholly - owned subsidiary LLP Interest received 0.00 Not Applicable 64.50 0.00 0.00 Any other NA 0.00 Not Applicable Loan 10.00 1 Unsecured As per the business needs
41 HealthCare Global Enterprises Limited HCG Oncology Hospitals LLP (formerly, Apex HCG Oncology Hospitals LLP) Wholly - owned subsidiary LLP Any other transaction Corporate guarantee commission income received 0.00 Not Applicable 2.48 0.00 0.00 Any other NA 0.00 Not Applicable
42 HealthCare Global Enterprises Limited HCG Oncology Hospitals LLP (formerly, Apex HCG Oncology Hospitals LLP) Wholly - owned subsidiary LLP Any other transaction Reimbursement of expense on employee stock option scheme cross charged by the Company 0.00 Not Applicable 10.40 0.00 0.00 Any other NA 0.00 Not Applicable
43 HealthCare Global Enterprises Limited HCG Oncology Hospitals LLP (formerly, Apex HCG Oncology Hospitals LLP) Wholly - owned subsidiary LLP Any other transaction Reimbursement of capital expenditure/ revenue expenditure cross charged by the Company 0.00 Not Applicable 241.30 0.00 0.00 Any other NA 0.00 Not Applicable
44 HealthCare Global Enterprises Limited HCG Oncology Hospitals LLP (formerly, Apex HCG Oncology Hospitals LLP) Wholly - owned subsidiary LLP Any other transaction Payments on behalf of 0.00 Not Applicable 244.60 0.00 0.00 Any other NA 0.00 Not Applicable
45 HealthCare Global Enterprises Limited HCG Oncology Hospitals LLP (formerly, Apex HCG Oncology Hospitals LLP) Wholly - owned subsidiary LLP Any other transaction Other payable 0.00 Not Applicable 45.98 22.04 78.60 Any other NA 0.00 Not Applicable
46 HealthCare Global Enterprises Limited HCG Oncology Hospitals LLP (formerly, Apex HCG Oncology Hospitals LLP) Wholly - owned subsidiary LLP Loan 0.00 Not Applicable 0.00 1,287.10 1,351.63 Any other NA 0.00 Not Applicable Loan 10.00 1 Unsecured As per the business needs
47 HCG Oncology Hospitals LLP (formerly, Apex HCG Oncology Hospitals LLP) HCG Manavata Oncology LLP Fellow Subsidiary Any other transaction Payments on behalf of 0.00 Not Applicable 0.00 0.62 0.24 Any other NA 0.00 Not Applicable
48 HCG Oncology Hospitals LLP (formerly, Apex HCG Oncology Hospitals LLP) HCG KOLKATA CANCER CARE LLP (Formerly known as HCG EKO Oncology LLP) Fellow Subsidiary Any other transaction Payments on behalf of 0.00 Not Applicable 0.00 6.19 4.74 Any other NA 0.00 Not Applicable
49 HealthCare Global Enterprises Limited HCG Manavata Oncology LLP Subsidiary LLP Any other transaction Corporate guarantee commission income received 19.00 Approved 9.70 0.00 0.00 Any other NA 0.00 Not Applicable
50 HealthCare Global Enterprises Limited HCG Manavata Oncology LLP Subsidiary LLP Any other transaction Reimbursement of capital expenditure/ revenue expenditure cross charged by the Company 33.90 Approved 33.90 148.90 182.80 Any other NA 0.00 Not Applicable
51 HealthCare Global Enterprises Limited HCG Manavata Oncology LLP Subsidiary LLP Any other transaction Payments on behalf of 0.00 Not Applicable 0.00 0.00 0.00 Any other NA 0.00 Not Applicable
52 HCG Manavata Oncology LLP VASANTRAO RUDRAPPA NAGARKAR MEDICAL FOUNDATION Company / entity in which KMP / Relatives of KMP can exercise significant influence Any other transaction Rent charges 0.00 Not Applicable 0.60 0.09 0.09 Any other NA 0.00 Not Applicable
53 HCG Manavata Oncology LLP RAJNISH VASANTRAO NAGARKAR HUF Company / entity in which KMP / Relatives of KMP can exercise significant influence Any other transaction Rent charges 0.00 Not Applicable 1.50 0.24 0.24 Any other NA 0.00 Not Applicable
54 HCG Manavata Oncology LLP Dr RAJ VASANTRAO NAGARKAR Partner Any other transaction Rent charges 464.92 Approved 459.69 0.00 70.12 Any other NA 0.00 Not Applicable
55 HCG Manavata Oncology LLP Dr RAJ VASANTRAO NAGARKAR Partner Any other transaction Medical Consultant fee 880.00 Approved 746.00 84.69 246.07 Any other NA 0.00 Not Applicable
56 HCG Manavata Oncology LLP Dr RAJ VASANTRAO NAGARKAR Partner Sale of goods or services 0.00 Not Applicable 1.46 0.63 0.46 Any other NA 0.00 Not Applicable
57 HCG Manavata Oncology LLP VASANTRAO RUDRAPPA NAGARKAR MEDICAL FOUNDATION Company / entity in which KMP / Relatives of KMP can exercise significant influence Sale of goods or services 0.00 Not Applicable 6.75 0.00 0.00 Any other NA 0.00 Not Applicable
58 HCG Manavata Oncology LLP KIMS Manavata Multi Speciality Hospital Company / entity in which KMP / Relatives of KMP can exercise significant influence Sale of goods or services 0.00 Not Applicable 11.50 56.30 59.15 Any other NA 0.00 Not Applicable
59 HCG Manavata Oncology LLP Dr RAJ VASANTRAO NAGARKAR Partner Interest paid 0.00 Not Applicable 37.60 0.00 0.00 Any other NA 0.00 Not Applicable Loan 10.00 1 Unsecured As per the business needs
60 HCG Manavata Oncology LLP HCG NCHRI Oncology LLP Fellow Subsidiary Interest paid 0.00 Not Applicable 37.60 0.00 0.00 Any other NA 0.00 Not Applicable Loan 10.00 1 Unsecured As per the business needs
61 HCG Manavata Oncology LLP Dr RAJ VASANTRAO NAGARKAR Partner Loan 0.00 Not Applicable 0.00 755.54 755.54 Any other NA 0.00 Not Applicable Loan 10.00 1 Unsecured As per the business needs
62 HCG Manavata Oncology LLP HCG NCHRI Oncology LLP Fellow Subsidiary Loan 0.00 Not Applicable 0.00 755.54 755.54 Any other NA 0.00 Not Applicable Loan 10.00 1 Unsecured As per the business needs
63 HealthCare Global Enterprises Limited Suchirayu Health Care Solutions Limited Subsidiary Company Sale of goods or services 308.50 Approved 146.67 106.90 123.90 Any other NA 0.00 Not Applicable
64 HealthCare Global Enterprises Limited Suchirayu Health Care Solutions Limited Subsidiary Company Purchase of goods or services 71.00 Approved 0.00 0.00 0.00 Any other NA 0.00 Not Applicable
65 HealthCare Global Enterprises Limited Suchirayu Health Care Solutions Limited Subsidiary Company Any other transaction Reimbursement of capital expenditure/ revenue expenditure cross charged by the Company 23.00 Approved 23.00 0.00 0.00 Any other NA 0.00 Not Applicable
66 HealthCare Global Enterprises Limited Suchirayu Health Care Solutions Limited Subsidiary Company Any other transaction Payments on behalf of 1.30 Approved 1.30 64.70 37.00 Any other NA 0.00 Not Applicable
67 Suchirayu Health Care Solutions Limited Noth Karnataka Sleep Center Company / entity in which KMP / Relatives of KMP can exercise significant influence Any other transaction Revenue Share 0.00 Not Applicable 0.00 0.00 0.00 Any other NA 0.00 Not Applicable
68 Suchirayu Health Care Solutions Limited Dr Rajendra Ishwarappa Dugani Director Any other transaction Medical Consultant fee 0.00 Not Applicable 56.80 7.57 9.50 Any other NA 0.00 Not Applicable
69 Suchirayu Health Care Solutions Limited Dr Sadashivayya Shadaksharayya Soppimath Director Any other transaction Medical Consultant fee 0.00 Not Applicable 37.80 3.10 6.90 Any other NA 0.00 Not Applicable
70 HealthCare Global Enterprises Limited Malnad Hospital & Institute of Oncology Private Limited Subsidiary Company Sale of goods or services 20.00 Approved 0.00 4.70 4.70 Any other NA 0.00 Not Applicable
71 HealthCare Global Enterprises Limited Malnad Hospital & Institute of Oncology Private Limited Subsidiary Company Purchase of goods or services 12.50 Approved 0.00 0.00 0.00 Any other NA 0.00 Not Applicable
72 HealthCare Global Enterprises Limited Malnad Hospital & Institute of Oncology Private Limited Subsidiary Company Any other transaction Reimbursement of capital expenditure/ revenue expenditure cross charged by the Company 11.80 Approved 11.80 0.00 0.00 Any other NA 0.00 Not Applicable
73 HealthCare Global Enterprises Limited Malnad Hospital & Institute of Oncology Private Limited Subsidiary Company Any other transaction Payments on behalf of 83.00 Approved 83.00 40.70 120.60 Any other NA 0.00 Not Applicable
74 HealthCare Global Enterprises Limited Malnad Hospital & Institute of Oncology Private Limited Subsidiary Company Any other transaction Interest accrued on loan/ capital contribution by subsidiaries 0.00 Not Applicable 0.00 30.00 30.00 Any other NA 0.00 Not Applicable
75 Malnad Hospital & Institute of Oncology Private Limited Sada Sarada Tumor & Research Institute Company / entity in which KMP / Relatives of KMP can exercise significant influence Advance 0.00 Not Applicable 9.10 77.70 86.76 Any other NA 0.00 Not Applicable
76 Malnad Hospital & Institute of Oncology Private Limited Sada Sarada Tumor & Research Institute Company / entity in which KMP / Relatives of KMP can exercise significant influence Any other transaction Rent charges 0.00 Not Applicable 15.33 0.00 0.00 Any other NA 0.00 Not Applicable
77 Malnad Hospital & Institute of Oncology Private Limited Gutti Malnad Hospital LLP Company / entity in which KMP / Relatives of KMP can exercise significant influence Any other transaction Security Deposit 0.00 Not Applicable 0.00 35.00 35.00 Any other NA 0.00 Not Applicable
78 Malnad Hospital & Institute of Oncology Private Limited Gutti Malnad Hospital LLP Company / entity in which KMP / Relatives of KMP can exercise significant influence Sale of goods or services 0.00 Not Applicable 0.00 13.50 13.50 Any other NA 0.00 Not Applicable
79 Malnad Hospital & Institute of Oncology Private Limited Malnad Hi-Tech Diagnostic Centre LLP Company / entity in which KMP / Relatives of KMP can exercise significant influence Purchase of goods or services 0.00 Not Applicable 0.00 13.86 13.86 Any other NA 0.00 Not Applicable
80 Malnad Hospital & Institute of Oncology Private Limited Malnad MRI Centre LLP Company / entity in which KMP / Relatives of KMP can exercise significant influence Purchase of goods or services 0.00 Not Applicable 0.00 0.02 0.02 Any other NA 0.00 Not Applicable
81 HealthCare Global Enterprises Limited BACC Healthcare Private Limited Subsidiary Company Sale of goods or services 0.00 Not Applicable 0.00 0.00 0.00 Any other NA 0.00 Not Applicable
82 HealthCare Global Enterprises Limited BACC Healthcare Private Limited Subsidiary Company Any other transaction Reimbursement of expense on employee stock option scheme cross charged by the Company 0.00 Not Applicable 1.40 0.00 0.00 Any other NA 0.00 Not Applicable
83 HealthCare Global Enterprises Limited BACC Healthcare Private Limited Subsidiary Company Any other transaction Reimbursement of capital expenditure/ revenue expenditure cross charged by the Company 0.00 Not Applicable 57.30 133.20 158.20 Any other NA 0.00 Not Applicable
84 HealthCare Global Enterprises Limited BACC Healthcare Private Limited Subsidiary Company Any other transaction Payments on behalf of 0.00 Not Applicable 0.00 0.00 0.00 Any other NA 0.00 Not Applicable
85 HealthCare Global Enterprises Limited BACC Healthcare Private Limited Subsidiary Company Any other transaction Other payable 0.00 Not Applicable 0.00 188.60 0.00 Any other NA 0.00 Not Applicable
86 HealthCare Global Enterprises Limited HCG KOLKATA CANCER CARE LLP (Formerly known as HCG EKO Oncology LLP) Wholly - owned subsidiary LLP Sale of goods or services 0.00 Not Applicable 0.00 17.10 17.10 Any other NA 0.00 Not Applicable
87 HealthCare Global Enterprises Limited HCG KOLKATA CANCER CARE LLP (Formerly known as HCG EKO Oncology LLP) Wholly - owned subsidiary LLP Sale of fixed assets 0.00 Not Applicable 0.00 0.00 0.00 Any other NA 0.00 Not Applicable
88 HealthCare Global Enterprises Limited HCG KOLKATA CANCER CARE LLP (Formerly known as HCG EKO Oncology LLP) Wholly - owned subsidiary LLP Any other transaction Finance lease income 0.00 Not Applicable 201.80 4,119.30 4,009.50 Any other NA 0.00 Not Applicable
89 HealthCare Global Enterprises Limited HCG KOLKATA CANCER CARE LLP (Formerly known as HCG EKO Oncology LLP) Wholly - owned subsidiary LLP Interest received 0.00 Not Applicable 52.60 0.00 0.00 Any other NA 0.00 Not Applicable Loan 10.00 1 Unsecured As per the business needs
90 HealthCare Global Enterprises Limited HCG KOLKATA CANCER CARE LLP (Formerly known as HCG EKO Oncology LLP) Wholly - owned subsidiary LLP Loan 0.00 Not Applicable 0.00 1,049.60 1,102.22 Any other NA 0.00 Not Applicable Loan 10.00 1 Unsecured As per the business needs
91 HealthCare Global Enterprises Limited HCG KOLKATA CANCER CARE LLP (Formerly known as HCG EKO Oncology LLP) Wholly - owned subsidiary LLP Any other transaction Corporate guarantee commission income received 0.00 Not Applicable 7.30 0.00 0.00 Any other NA 0.00 Not Applicable
92 HealthCare Global Enterprises Limited HCG KOLKATA CANCER CARE LLP (Formerly known as HCG EKO Oncology LLP) Wholly - owned subsidiary LLP Any other transaction Reimbursement of expense on employee stock option scheme cross charged by the Company 0.00 Not Applicable 4.60 0.00 0.00 Any other NA 0.00 Not Applicable
93 HealthCare Global Enterprises Limited HCG KOLKATA CANCER CARE LLP (Formerly known as HCG EKO Oncology LLP) Wholly - owned subsidiary LLP Any other transaction Reimbursement of capital expenditure/ revenue expenditure cross charged by the Company 0.00 Not Applicable 77.40 0.00 0.00 Any other NA 0.00 Not Applicable
94 HealthCare Global Enterprises Limited HCG KOLKATA CANCER CARE LLP (Formerly known as HCG EKO Oncology LLP) Wholly - owned subsidiary LLP Any other transaction Payments on behalf of 0.00 Not Applicable 189.30 994.00 1,230.30 Any other NA 0.00 Not Applicable
95 HealthCare Global Enterprises Limited HCG KOLKATA CANCER CARE LLP (Formerly known as HCG EKO Oncology LLP) Wholly - owned subsidiary LLP Any other transaction Interest accrued on loan/ capital contribution by subsidiaries 0.00 Not Applicable 0.00 146.10 146.10 Any other NA 0.00 Not Applicable
96 HealthCare Global Enterprises Limited HCG KOLKATA CANCER CARE LLP (Formerly known as HCG EKO Oncology LLP) Wholly - owned subsidiary LLP Any other transaction Allowance for doubtful trade receivables 0.00 Not Applicable 0.00 21.10 21.10 Any other NA 0.00 Not Applicable
97 HealthCare Global Enterprises Limited HCG RAJKOT HOSPITALS LLP (Formerly known as HCG Sun Hospitals LLP) Wholly - owned subsidiary LLP Sale of goods or services 0.00 Not Applicable 0.00 136.70 136.70 Any other NA 0.00 Not Applicable
98 HealthCare Global Enterprises Limited HCG RAJKOT HOSPITALS LLP (Formerly known as HCG Sun Hospitals LLP) Wholly - owned subsidiary LLP Any other transaction Corporate guarantee commission income received 0.00 Not Applicable 3.60 0.00 0.00 Any other NA 0.00 Not Applicable
99 HealthCare Global Enterprises Limited HCG RAJKOT HOSPITALS LLP (Formerly known as HCG Sun Hospitals LLP) Wholly - owned subsidiary LLP Any other transaction Reimbursement of expense on employee stock option scheme cross charged by the Company 0.00 Not Applicable 2.20 0.00 0.00 Any other NA 0.00 Not Applicable
100 HealthCare Global Enterprises Limited HCG RAJKOT HOSPITALS LLP (Formerly known as HCG Sun Hospitals LLP) Wholly - owned subsidiary LLP Any other transaction Reimbursement of capital expenditure/ revenue expenditure cross charged by the Company 0.00 Not Applicable 142.70 0.00 0.00 Any other NA 0.00 Not Applicable
101 HealthCare Global Enterprises Limited HCG RAJKOT HOSPITALS LLP (Formerly known as HCG Sun Hospitals LLP) Wholly - owned subsidiary LLP Any other transaction Payments on behalf of 0.00 Not Applicable 5.70 412.00 529.70 Any other NA 0.00 Not Applicable
102 HealthCare Global Enterprises Limited HCG RAJKOT HOSPITALS LLP (Formerly known as HCG Sun Hospitals LLP) Wholly - owned subsidiary LLP Purchase of goods or services 0.00 Not Applicable 0.00 6.60 0.00 Any other NA 0.00 Not Applicable
103 HealthCare Global Enterprises Limited HCG NCHRI Oncology LLP Wholly - owned subsidiary LLP Loan 0.00 Not Applicable 0.00 1,439.04 1,511.19 Any other NA 0.00 Not Applicable Loan 10.00 1 Unsecured As per the business needs
104 HealthCare Global Enterprises Limited HCG NCHRI Oncology LLP Wholly - owned subsidiary LLP Interest received 0.00 Not Applicable 72.10 0.00 0.00 Any other NA 0.00 Not Applicable Loan 10.00 1 Unsecured As per the business needs
105 HealthCare Global Enterprises Limited HCG NCHRI Oncology LLP Wholly - owned subsidiary LLP Any other transaction Interest accrued on loan/ capital contribution by subsidiaries 0.00 Not Applicable 0.00 293.50 293.50 Any other NA 0.00 Not Applicable
106 HealthCare Global Enterprises Limited Nagpur Cancer Hospital and Research Institute Pvt Ltd Subsidiary Company Any other transaction Allowance for doubtful trade receivables 0.00 Not Applicable 0.00 824.00 824.00 Any other NA 0.00 Not Applicable
107 HealthCare Global Enterprises Limited Vizag Hospital and Cancer Research Center Private Limited Subsidiary Company Sale of goods or services 65.00 Approved 0.00 0.00 0.00 Any other NA 0.00 Not Applicable
108 HealthCare Global Enterprises Limited Vizag Hospital and Cancer Research Center Private Limited Subsidiary Company Purchase of goods or services 25.00 Approved 11.60 0.00 11.60 Any other NA 0.00 Not Applicable
109 HealthCare Global Enterprises Limited Vizag Hospital and Cancer Research Center Private Limited Subsidiary Company Any other transaction Reimbursement of capital expenditure/ revenue expenditure cross charged by the Company 31.20 Approved 31.20 0.00 40.70 Any other NA 0.00 Not Applicable
110 Vizag Hospital and Cancer Research Center Private Limited Dr V Murali Krishna Company / entity in which KMP / Relatives of KMP can exercise significant influence Any other transaction Medical Consultant fee 0.00 Not Applicable 262.53 98.70 101.25 Any other NA 0.00 Not Applicable
111 Vizag Hospital and Cancer Research Center Private Limited Voonna Srinivas Rao Company / entity in which KMP / Relatives of KMP can exercise significant influence Any other transaction Rent 0.00 Not Applicable 3.33 0.40 0.00 Any other NA 0.00 Not Applicable
112 Vizag Hospital and Cancer Research Center Private Limited Dr Sitaramaswamy Vonna Company / entity in which KMP / Relatives of KMP can exercise significant influence Any other transaction Medical Consultant fee 0.00 Not Applicable 0.00 0.00 0.00 Any other NA 0.00 Not Applicable
113 HealthCare Global Enterprises Limited Healthcare Diwan Chand Imaging LLP Subsidiary LLP Any other transaction Other payable 0.00 Not Applicable 0.00 25.30 25.30 Any other NA 0.00 Not Applicable
114 HealthCare Global Enterprises Limited Healthcare Diwan Chand Imaging LLP Subsidiary LLP Purchase of goods or services 0.00 Not Applicable 0.00 246.30 246.30 Any other NA 0.00 Not Applicable
115 HealthCare Global Enterprises Limited Cancer Care Kenya Limited Wholly - owned subsidiary LLP Any other transaction Reimbursement of capital expenditure/ revenue expenditure cross charged by the Company 0.00 Not Applicable 7.06 7.30 14.46 Any other NA 0.00 Not Applicable
116 HealthCare Global Enterprises Limited HCG (Mauritius) Private Limited Wholly - owned subsidiary LLP Investment 0.00 Not Applicable 0.00 3,552.40 3,552.40 Any other NA 0.00 Not Applicable
117 HealthCare Global Enterprises Limited Rajiv Maliwal Independent Directors Any other transaction Sitting fees to Directors 0.00 Not Applicable 20.65 0.00 0.00 Any other NA 0.00 Not Applicable
118 HealthCare Global Enterprises Limited Pradip M. Kanakia Independent Directors Any other transaction Sitting fees to Directors 0.00 Not Applicable 20.65 0.00 0.00 Any other NA 0.00 Not Applicable
119 HealthCare Global Enterprises Limited Geeta Mathur Independent Directors Any other transaction Sitting fees to Directors 0.00 Not Applicable 20.65 0.00 0.00 Any other NA 0.00 Not Applicable
120 HealthCare Global Enterprises Limited Rajagopalan Raghavan Independent Directors Any other transaction Sitting fees to Directors 0.00 Not Applicable 20.65 0.00 0.00 Any other NA 0.00 Not Applicable
121 HealthCare Global Enterprises Limited Dr. B S Ajaikumar Whole-time director Remuneration 0.00 Not Applicable 100.00 370.04 0.00 Any other NA 0.00 Not Applicable Textual Information(1)
122 HealthCare Global Enterprises Limited Dr. B S Ajaikumar Non-Executive Director, Promoter Any other transaction Medical Consultant fee 0.00 Not Applicable 90.32 0.00 29.99 Any other NA 0.00 Not Applicable Textual Information(2)
123 HealthCare Global Enterprises Limited Ms. Anjali Ajaikumar Whole-time director Remuneration 0.00 Not Applicable 20.83 39.50 0.00 Any other NA 0.00 Not Applicable Textual Information(3)
124 HealthCare Global Enterprises Limited Ms. Anjali Ajaikumar Non-Execuitve Director Any other transaction Professional Services 0.00 Not Applicable 33.87 0.00 10.25 Any other NA 0.00 Not Applicable Textual Information(4)
125 HealthCare Global Enterprises Limited Meghraj Arvindrao Gore Key Managerial Personnel Remuneration 0.00 Not Applicable 110.25 130.30 27.77 Any other NA 0.00 Not Applicable Textual Information(5)
126 HealthCare Global Enterprises Limited Meghraj Arvindrao Gore Key Managerial Personnel Any other transaction Share based payments 0.00 Not Applicable 44.98 0.00 0.00 Any other NA 0.00 Not Applicable Textual Information(6)
127 HealthCare Global Enterprises Limited Ruby Ritolia Key Managerial Personnel Remuneration 0.00 Not Applicable 46.68 48.36 7.01 Any other NA 0.00 Not Applicable Textual Information(7)
128 HealthCare Global Enterprises Limited Ruby Ritolia Key Managerial Personnel Any other transaction Share based payments 0.00 Not Applicable 5.99 0.00 0.00 Any other NA 0.00 Not Applicable Textual Information(8)
129 HealthCare Global Enterprises Limited Sunu Manuel Key Managerial Personnel Remuneration 0.00 Not Applicable 35.41 6.77 12.48 Any other NA 0.00 Not Applicable
130 HealthCare Global Enterprises Limited Sunu Manuel Key Managerial Personnel Any other transaction Share based payments 0.00 Not Applicable 3.27 0.00 0.00 Any other NA 0.00 Not Applicable
131 HealthCare Global Enterprises Limited Dr Manish Mattoo Key Managerial Personnel Remuneration 0.00 Not Applicable 128.49 0.00 86.19 Any other NA 0.00 Not Applicable Textual Information(9)
Total value of transaction during the reporting period 16,904.95



Text Block

Textual Information(1) Upto 30 May 2025
Textual Information(2) W.e.f 10 August 2025
Textual Information(3) Upto 30 May 2025
Textual Information(4) W.e.f 10 August 2025
Textual Information(5) Up to 30 June 2025
Textual Information(6) Up to 30 June 2025
Textual Information(7) Upto 02 September 2025
Textual Information(8) Upto 02 September 2025
Textual Information(9) W.e.f 30 June 2025